Navigation Links
National Hemophilia Foundation Asks America to Make a Difference With National Fundraising Initiative
Date:4/17/2008

National Walk to help raise money for crucial research, advocacy and

education

NEW YORK, April 17 /PRNewswire/ -- The National Hemophilia Foundation (NHF) today announced its first-ever national fundraising and awareness campaign -- the Hemophilia Walk, presented nationally by Baxter Healthcare Corporation. As part of this initiative, the NHF will partner with local chapters in five cities across the U.S. to raise much needed funding to help find better treatments and cures for hemophilia and other bleeding and clotting disorders, increase awareness about these conditions and promote early diagnosis, and provide education to help those with bleeding disorders avoid complications.

The Hemophilia Walk will kick off in New York City on June 1, and Walks are scheduled in four other cities on the following days:

-- Houston, TX - September 6

-- Cleveland, OH - September 20

-- Phoenix, AZ - September 28

-- Raleigh, NC - October 18

"We are very excited about announcing the launch of this first-ever nationwide fundraising initiative," said Howard Balsam, interim chief executive officer, National Hemophilia Foundation. "These walks will help the NHF on both a local and national level, advancing and strengthening our overall mission of finding better treatments and cures and, until that time, helping all those with bleeding and clotting disorders live longer more healthy lives."

The official Hemophilia Walk Web site, http://www.hemophilia.org/walk/, provides a quick and easy way to learn more about the individual Hemophilia Walks and for participants to register for the Walk of their choice.

Once registered, participants can conduct individual fundraising efforts as part of a team, or by creating a team of their own. To help make this process even easier, the NHF has partnered with Active.com to provide an easy and secure way to conduct fundraising online.

"Baxter is proud to be the national presenting sponsor of the NHF Hemophilia Walk," said John Shannon, vice president of marketing, Baxter Healthcare. "Millions of Americans live with bleeding disorders, including hemophilia, which can cause crippling disabilities, particularly if left untreated. At Baxter, we are committed to supporting programs that raise awareness, educate and help improve the lives of people living with these conditions.

About Hemophilia

Approximately 400,000 people around the world have hemophilia. Hemophilia is an inherited bleeding disorder that can affect families over generations, and is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. While advances in therapies have given those with hemophilia a chance for longer and healthier lives, there is still no cure. The disease is caused by deficient or defective blood coagulation proteins, known as factor VIII or IX. The most common form of the disease is hemophilia A, or classic hemophilia, in which the clotting factor VIII is either deficient or defective. Hemophilia B is characterized by deficient or defective factor IX.

About the National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.


'/>"/>
SOURCE National Hemophilia Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. National Indoor Comfort Week - A Breath of Fresh Air for Allergy Sufferers
2. The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing
3. The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award
4. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
5. Live Webcast of SBAs National Small Business Week Policy Forums Scheduled
6. Statement by SEIU International President Andy Stern Regarding CNA Temporary Restraining Order
7. National Restaurant Association Expresses Disappointment About Court Ruling on Menu Labeling in New York City
8. More Than 350 Events Today in Recognition of First National Healthcare Decisions Day
9. Jenni Schaefer, Motivational Speaker, Author Named National Eating Disorders Association (NEDA) Ambassador
10. China Sky One Medical, Inc. Announces Its Successful Participation in the 20th International Medical Instruments and Equipment Exhibition
11. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... , drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's ... facets of clinical trial planning and management. Pharmica discussed the importance of effective ... addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Noble Capital Markets ... ESSA Pharma Inc. (Nasdaq: EPIX ). The ... Kumar Raja , PhD. ESSA Pharmaceuticals ... castration resistant prostate cancer (CRPC). Its lead compound EPI-506, ... the amino-terminal domain of the androgen receptor, thereby has ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today announced results ... Net income attributable to DaVita Inc. for the ... or $0.80 per share and $880 million, or $4.29 per ... DaVita Inc. for the quarter and year ended December 31, ... or $0.98 per share, and $789 million, or $3.85 per ...
Breaking Medicine Technology: